CaĆeda, Rhyle M.
HRN: 25-67-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
10/02/2024
10/05/2024
IV
11mg
Q24H
Psnb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes